Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 Apr 27;312(7038):1069–1074. doi: 10.1136/bmj.312.7038.1069

Randomised study of n of 1 trials versus standard practice.

J Mahon 1, A Laupacis 1, A Donner 1, T Wood 1
PMCID: PMC2350863  PMID: 8616414

Abstract

OBJECTIVE--To compare outcomes between groups of patients with irreversible chronic airflow limitation given theophylline by n of 1 trials or standard practice. DESIGN--Randomised controlled study of n of 1 trials versus standard practice. SETTING--Tertiary care center outpatient department. SUBJECTS--31 patients with irreversible chronic airflow limitation who were unsure that theophylline was helpful after an open trial. INTERVENTIONS--n Of 1 trials (single patient randomised multiple crossover comparisons of theophylline against placebo) followed published guidelines. For standard practice patients theophylline was stopped and resumed if their dyspnoea worsened; if their dyspnoea then improved theophylline was continued. For both groups a decision to continue or stop the drug was made within three months of randomisation. MAIN OUTCOME MEASURES--Exercise capacity as measured by six minute walking distance, quality of life as measured by the chronic respiratory disease questionnaire at baseline and six months after randomisation, and proportions of patients taking theophylline at six months. RESULTS--26 patients completed follow up. 47% fewer n of 1 trial patients than standard practice patients were taking theophylline at six months (5/14 versus 10/12; 95% confidence interval of difference 14% to 80%) without differences in exercise capacity or quality of life. CONCLUSIONS--n Of 1 trials led to less theophylline use without adverse effects on exercise capacity or quality of life in patients with irreversible chronic airflow limitation. These data directly support the presence of a clinically important bias towards unnecessary treatment during open prescription of theophylline for irreversible chronic airflow limitation. Confirmation in a larger study and similar studies for other problems appropriate for n of 1 trials are needed before widespread use of n of 1 trials can be advocated in routine clinical practice.

Full text

PDF
1069

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruera E., Schoeller T., MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage. 1992 Aug;7(6):365–368. doi: 10.1016/0885-3924(92)90091-u. [DOI] [PubMed] [Google Scholar]
  2. Dales R. E., Lunau M. A., Tierney M. G., Schweitzer I. Chronic cough responsive to ibuprofen. Pharmacotherapy. 1992;12(4):331–333. [PubMed] [Google Scholar]
  3. Guyatt G. H., Berman L. B., Townsend M., Pugsley S. O., Chambers L. W. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 Oct;42(10):773–778. doi: 10.1136/thx.42.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Guyatt G. H., Heyting A., Jaeschke R., Keller J., Adachi J. D., Roberts R. S. N of 1 randomized trials for investigating new drugs. Control Clin Trials. 1990 Apr;11(2):88–100. doi: 10.1016/0197-2456(90)90003-k. [DOI] [PubMed] [Google Scholar]
  5. Guyatt G. H., Keller J. L., Jaeschke R., Rosenbloom D., Adachi J. D., Newhouse M. T. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med. 1990 Feb 15;112(4):293–299. doi: 10.7326/0003-4819-112-4-293. [DOI] [PubMed] [Google Scholar]
  6. Guyatt G. H., Townsend M., Pugsley S. O., Keller J. L., Short H. D., Taylor D. W., Newhouse M. T. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis. 1987 May;135(5):1069–1074. doi: 10.1164/arrd.1987.135.5.1069. [DOI] [PubMed] [Google Scholar]
  7. Guyatt G., Sackett D., Adachi J., Roberts R., Chong J., Rosenbloom D., Keller J. A clinician's guide for conducting randomized trials in individual patients. CMAJ. 1988 Sep 15;139(6):497–503. [PMC free article] [PubMed] [Google Scholar]
  8. Guyatt G., Sackett D., Taylor D. W., Chong J., Roberts R., Pugsley S. Determining optimal therapy--randomized trials in individual patients. N Engl J Med. 1986 Apr 3;314(14):889–892. doi: 10.1056/NEJM198604033141406. [DOI] [PubMed] [Google Scholar]
  9. Hoogwerf B. J. Amitriptyline treatment of painful diabetic neuropathy: an inadvertent single-patient clinical trial. Diabetes Care. 1985 Sep-Oct;8(5):526–527. doi: 10.2337/diacare.8.5.526. [DOI] [PubMed] [Google Scholar]
  10. Irwig L., Glasziou P., March L. Ethics of n-of-1 trials. Lancet. 1995 Feb 25;345(8948):469–469. doi: 10.1016/s0140-6736(95)90578-2. [DOI] [PubMed] [Google Scholar]
  11. Jaeschke R., Adachi J., Guyatt G., Keller J., Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991 Mar;18(3):447–451. [PubMed] [Google Scholar]
  12. Jaeschke R., Singer J., Guyatt G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407–415. doi: 10.1016/0197-2456(89)90005-6. [DOI] [PubMed] [Google Scholar]
  13. Johannessen T. Controlled trials in single subjects. 1. Value in clinical medicine. BMJ. 1991 Jul 20;303(6795):173–174. doi: 10.1136/bmj.303.6795.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johannessen T., Petersen H., Kristensen P., Fosstvedt D., Kleveland P. M., Dybdahl J., Løge I. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scand J Gastroenterol. 1992;27(3):189–195. doi: 10.3109/00365529208999947. [DOI] [PubMed] [Google Scholar]
  15. Larson E. B., Ellsworth A. J., Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA. 1993 Dec 8;270(22):2708–2712. [PubMed] [Google Scholar]
  16. Levitt A. J., Lippert G. P. Psychogenic panic after zidovudine therapy: the therapeutic benefit of an N of 1 trial. CMAJ. 1990 Feb 15;142(4):341–342. [PMC free article] [PubMed] [Google Scholar]
  17. Links P. S., Boiago I. N of 1 randomized control trial for BPD patients. Can J Psychiatry. 1992 Mar;37(2):148–148. doi: 10.1177/070674379203700223. [DOI] [PubMed] [Google Scholar]
  18. March L., Irwig L., Schwarz J., Simpson J., Chock C., Brooks P. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ. 1994 Oct 22;309(6961):1041–1046. doi: 10.1136/bmj.309.6961.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McLeod R. S., Taylor D. W., Cohen Z., Cullen J. B. Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet. 1986 Mar 29;1(8483):726–728. doi: 10.1016/s0140-6736(86)91112-8. [DOI] [PubMed] [Google Scholar]
  20. Murciano D., Auclair M. H., Pariente R., Aubier M. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med. 1989 Jun 8;320(23):1521–1525. doi: 10.1056/NEJM198906083202304. [DOI] [PubMed] [Google Scholar]
  21. Newhouse M. T. Is theophylline obsolete? Chest. 1990 Jul;98(1):1–3. doi: 10.1378/chest.98.1.1. [DOI] [PubMed] [Google Scholar]
  22. Nuovo J., Ellsworth A. J., Larson E. B. Treatment of atopic dermatitis with antihistamines: lessons from a single-patient, randomized clinical trial. J Am Board Fam Pract. 1992 Mar-Apr;5(2):137–141. [PubMed] [Google Scholar]
  23. Patel A., Jaeschke R., Guyatt G. H., Keller J. L., Newhouse M. T. Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation. Am Rev Respir Dis. 1991 Oct;144(4):962–964. doi: 10.1164/ajrccm/144.4.962. [DOI] [PubMed] [Google Scholar]
  24. Porta M. S. The search for more clinically meaningful research designs: single-patient randomized clinical trials. J Gen Intern Med. 1986 Nov-Dec;1(6):418–419. doi: 10.1007/BF02596430. [DOI] [PubMed] [Google Scholar]
  25. Robin E. D., Burke C. M. Single-patient randomized clinical trial. Opiates for intractable dyspnea. Chest. 1986 Dec;90(6):888–892. doi: 10.1378/chest.90.6.888. [DOI] [PubMed] [Google Scholar]
  26. White J. C., Christensen J. F., Singer C. M. Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial. J Clin Psychiatry. 1992 May;53(5):153–156. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES